Integrated Investment Consultants LLC Buys 237 Shares of The Cigna Group (NYSE:CI)

Integrated Investment Consultants LLC grew its position in shares of The Cigna Group (NYSE:CI) by 28.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,074 shares of the health services provider’s stock after buying an additional 237 shares during the quarter. Integrated Investment Consultants LLC’s holdings in The Cigna Group were worth $372,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CI. CreativeOne Wealth LLC purchased a new position in shares of The Cigna Group in the first quarter worth approximately $454,000. Lazard Asset Management LLC boosted its stake in shares of The Cigna Group by 54.3% during the 1st quarter. Lazard Asset Management LLC now owns 185,295 shares of the health services provider’s stock worth $67,296,000 after acquiring an additional 65,193 shares during the last quarter. BOKF NA boosted its stake in shares of The Cigna Group by 14.3% during the 1st quarter. BOKF NA now owns 5,381 shares of the health services provider’s stock worth $1,959,000 after acquiring an additional 673 shares during the last quarter. QVR LLC bought a new stake in shares of The Cigna Group during the 1st quarter valued at $392,000. Finally, SVB Wealth LLC increased its stake in shares of The Cigna Group by 5.2% in the 1st quarter. SVB Wealth LLC now owns 9,554 shares of the health services provider’s stock worth $3,470,000 after purchasing an additional 474 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

The Cigna Group Stock Performance

NYSE:CI opened at $328.43 on Friday. The company has a market cap of $91.35 billion, a price-to-earnings ratio of 30.98, a PEG ratio of 0.97 and a beta of 0.51. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.83. The stock’s 50 day simple moving average is $335.43 and its two-hundred day simple moving average is $338.87. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same period last year, the firm posted $6.77 earnings per share. The Cigna Group’s revenue for the quarter was up 29.8% compared to the same quarter last year. As a group, equities analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s payout ratio is 52.83%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CI. Jefferies Financial Group lifted their target price on The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. increased their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Barclays raised their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $394.64.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.